Salud financiera de hoja de balance de Dr. Lal PathLabs
Salud financiera controles de criterios 5/6
Dr. Lal PathLabs tiene un patrimonio de accionistas total de ₹20.4B y una deuda total de ₹417.0M, lo que sitúa su ratio deuda-patrimonio en 2%. Sus activos y pasivos totales son ₹26.0B y ₹5.6B respectivamente. El BAIT de Dr. Lal PathLabs es de ₹5.2B, por lo que su ratio de cobertura de intereses es de -17.3. Tiene efectivo e inversiones a corto plazo que ascienden a ₹11.3B.
Información clave
2.0%
Ratio deuda-patrimonio
₹417.00m
Deuda
| Ratio de cobertura de intereses | -17.3x |
| Efectivo | ₹11.27b |
| Patrimonio | ₹20.35b |
| Total pasivo | ₹5.62b |
| Activos totales | ₹25.98b |
Actualizaciones recientes sobre salud financiera
These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely
Jul 28
These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely
Mar 06Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?
Nov 17Here's Why Dr. Lal PathLabs (NSE:LALPATHLAB) Can Manage Its Debt Responsibly
Jul 07Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?
Dec 29These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Reasonably Well
Sep 01Recent updates
Analysts Are Updating Their Dr. Lal PathLabs Limited (NSE:LALPATHLAB) Estimates After Its Second-Quarter Results
Oct 26Capital Investment Trends At Dr. Lal PathLabs (NSE:LALPATHLAB) Look Strong
Oct 24Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) Share Price Could Signal Some Risk
Oct 06These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely
Jul 28We Think Dr. Lal PathLabs' (NSE:LALPATHLAB) Profit Is Only A Baseline For What They Can Achieve
May 21What Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) P/E Is Not Telling You
May 01Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital
Apr 13These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely
Mar 06Dr. Lal PathLabs Limited Just Missed EPS By 5.4%: Here's What Analysts Think Will Happen Next
Feb 04Subdued Growth No Barrier To Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) Price
Dec 28Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?
Nov 17Dr. Lal PathLabs (NSE:LALPATHLAB) Will Be Hoping To Turn Its Returns On Capital Around
Oct 12Here's Why Dr. Lal PathLabs (NSE:LALPATHLAB) Can Manage Its Debt Responsibly
Jul 07Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital
Jun 10Dr. Lal PathLabs (NSE:LALPATHLAB) Could Be Struggling To Allocate Capital
Feb 13Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?
Dec 29Dr. Lal PathLabs (NSE:LALPATHLAB) Will Want To Turn Around Its Return Trends
Sep 21These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Reasonably Well
Sep 01Dr. Lal PathLabs (NSE:LALPATHLAB) Will Pay A Dividend Of ₹6.00
Jul 31Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital
Jun 23Does This Valuation Of Dr. Lal PathLabs Limited (NSE:LALPATHLAB) Imply Investors Are Overpaying?
Jun 11Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (₹13.3B) de LALPATHLAB superan a sus pasivos a corto plazo (₹4.6B).
Pasivo a largo plazo: Los activos a corto plazo de LALPATHLAB (₹13.3B) superan a sus pasivos a largo plazo (₹999.0M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: LALPATHLAB tiene más efectivo que su deuda total.
Reducción de la deuda: El ratio deuda-patrimonio de LALPATHLAB ha crecido de 0% a 2% en los últimos 5 años.
Cobertura de la deuda: La deuda de LALPATHLAB está bien cubierta por el flujo de caja operativo (1286.7%).
Cobertura de intereses: LALPATHLAB gana más intereses de los que paga, por lo que la cobertura de pagos de intereses no es preocupante.